Pfizer’s Antiviral Pill for Covid Has Excellent Results

New data recently released by Pfizer demonstrates that Paxlovid, the antiviral pill the company created to treat Covid patients, can reduce the risk of hospitalization or death by nearly 90% in high-risk adults. Pfizer also announced that preliminary results from a second study have shown that adult patients with a standard risk profile who take Paxlovid within a few days of showing symptoms of the virus have a 70% reduction of hospitalization and death.